eXoZymes, Inc. Cash Flow Conversion Efficiency
eXoZymes, Inc. cash flow conversion efficiency. Based on the latest financial reports, eXoZymes, Inc. (EXOZ) has a cash flow conversion efficiency ratio of -0.998x as of March 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($-1.52 Million) by net assets ($1.53 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Cash Flow Conversion Efficiency of eXoZymes, Inc. (2021–2025)
Cash flow conversion efficiency of eXoZymes, Inc. from 2021 to 2025. This chart illustrates how eXoZymes, Inc.'s cash flow conversion efficiency has evolved over time, based on yearly financial data. View current stock price of eXoZymes, Inc. for real-time trading data and today's change.
eXoZymes, Inc. Cash Flow Conversion Ratio Explained
eXoZymes, Inc. cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.
eXoZymes, Inc. Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of eXoZymes, Inc. ranked by their cash flow conversion efficiency. Also see market value of eXoZymes, Inc. for the company's overall valuation and market capitalisation.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
HS Valve Co. Ltd
KQ:039610
|
0.001x |
|
Tolins Tyres Ltd
NSE:TOLINS
|
N/A |
|
Suparma Tbk
JK:SPMA
|
0.049x |
|
Star Comgistic Capital Co Ltd
TW:4930
|
-0.036x |
|
HYUNDAI BIOLAND Co.Ltd
KQ:052260
|
0.102x |
|
Retail Food Group Ltd
AU:RFG
|
0.000x |
|
Helixmith Co. Ltd
KQ:084990
|
-0.010x |
|
Shanghai Guijiu Co Ltd
SHG:600696
|
0.031x |
Annual Cash Flow Conversion Efficiency for eXoZymes, Inc. (2021–2025)
The table below shows the annual cash flow conversion efficiency of eXoZymes, Inc. from 2021 to 2025. Review how much free cash does eXoZymes, Inc. generate to assess how much free cash flow the company generates relative to operating cash flow.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | $3.40 Million | $-6.50 Million | -1.914x | -134.48% |
| 2024-12-31 | $10.42 Million | $-8.51 Million | -0.816x | -126.56% |
| 2023-12-31 | $-384.32K | $-1.18 Million | 3.073x | +435.48% |
| 2022-12-31 | $1.37 Million | $-1.26 Million | -0.916x | +30.90% |
| 2021-12-31 | $1.20 Million | $-1.59 Million | -1.325x | -- |
About eXoZymes, Inc.
eXoZymes, Inc. operates as a development stage biotechnology company. It focuses on the development of enzyme modules and cell-free exozyme biosolutions for synthetic biology manufacturing. The company was formerly known as Invizyne Technologies, Inc. and changed its name to eXoZymes, Inc. in February 2025. eXoZymes, Inc. was incorporated in 2014 and is headquartered in Monrovia, California.